New Zealand markets closed

Yandex N.V. (YNDX)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
18.940.00 (0.00%)
As of 04:00PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 6.80B
Enterprise value 7.94B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.04
Price/book (mrq)1.70
Enterprise value/revenue 0.01
Enterprise value/EBITDA 0.07

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 30.00%
S&P500 52-week change 321.23%
52-week high 318.94
52-week low 318.94
50-day moving average 318.94
200-day moving average 318.94

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5325.88M
Implied shares outstanding 6358.88M
Float 8318.47M
% held by insiders 12.23%
% held by institutions 127.05%
Shares short (28 Mar 2024) 43.55M
Short ratio (28 Mar 2024) 4N/A
Short % of float (28 Mar 2024) 41.09%
Short % of shares outstanding (28 Mar 2024) 40.89%
Shares short (prior month 29 Feb 2024) 43.55M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in RUB.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 2.48%
Operating margin (ttm)1.17%

Management effectiveness

Return on assets (ttm)2.64%
Return on equity (ttm)6.86%

Income statement

Revenue (ttm)800.13B
Revenue per share (ttm)2,157.60
Quarterly revenue growth (yoy)51.50%
Gross profit (ttm)N/A
EBITDA 69.55B
Net income avi to common (ttm)19.87B
Diluted EPS (ttm)-1.22
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)96.52B
Total cash per share (mrq)267.01
Total debt (mrq)194.64B
Total debt/equity (mrq)65.69%
Current ratio (mrq)0.89
Book value per share (mrq)819.61

Cash flow statement

Operating cash flow (ttm)70.28B
Levered free cash flow (ttm)68.64B